FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048376658> ?p ?o ?g. }

• W3048376658 endingPage "401" @default.
• W3048376658 startingPage "394" @default.
• W3048376658 abstract "Objective To determine the impact on overall survival (OS) of different modalities of adjuvant therapy for the treatment of stage III endometrial cancer (EC), by histology. Methods Stage 3 endometrioid (EAC), serous (SER), clear cell (CC), and carcinosarcoma (CS) patients who underwent primary surgical staging from 2000 to 2013 were identified in SEER-Medicare. Adjuvant therapy was defined by a 4-arm comparator grouping (none; RT only; CT only; combination RT), as well as by an 8-arm comparator grouping (none; RT only; CT only; concurrent CT-RT; concurrent CT-RT then CT; Serial CT-RT; serial RT-CT; sandwich). Modality of RT and CT were analyzed using Kaplan-Meier estimates, log rank tests, and multivariable cox modeling. Results Of 2870 cases identified (1798 EAC, 606 SER, 118 CC, 348 CS), 31.5% received no adjuvant therapy. The remainder received RT or CT alone, concurrent RT-CT, serial or sandwich modalities. OS differed by adjuvant therapy in adjusted and unadjusted models, when combining all histologies, and when stratifying by histology using both the 4-arm, and 8-arm comparator analyses (log rank p < .05, all). By histology, in adjusted analyses, sandwich modality had the greatest improvement in OS for endometrioid, but pairwise comparisons did not identify a superior chemotherapy-based regimen. For serous and clear cell, the greatest improvement in OS was seen with concurrent RT-CT, and for carcinosarcoma, CT alone. Conclusions OS for advanced EC significantly differs by histology and mode of adjuvant therapy. Future studies should evaluate the efficacy of combination-based adjuvant therapy versus chemotherapy alone, by histologic subtype and molecular signature." @default.
• W3048376658 created "2020-08-18" @default.
• W3048376658 creator A5003929069 @default.
• W3048376658 creator A5026950248 @default.
• W3048376658 creator A5027202188 @default.
• W3048376658 creator A5031453430 @default.
• W3048376658 creator A5034744116 @default.
• W3048376658 creator A5036514898 @default.
• W3048376658 creator A5068319278 @default.
• W3048376658 creator A5075065928 @default.
• W3048376658 creator A5078818153 @default.
• W3048376658 creator A5089503365 @default.
• W3048376658 date "2020-11-01" @default.
• W3048376658 modified "2023-10-17" @default.
• W3048376658 title "Utilization and survival outcomes of sequential, concurrent and sandwich therapies for advanced stage endometrial cancers by histology" @default.
• W3048376658 cites W1544539327 @default.
• W3048376658 cites W1967890742 @default.
• W3048376658 cites W1999911762 @default.
• W3048376658 cites W2038011108 @default.
• W3048376658 cites W2041440766 @default.
• W3048376658 cites W2054791534 @default.
• W3048376658 cites W2098960933 @default.
• W3048376658 cites W2102223796 @default.
• W3048376658 cites W2108556797 @default.
• W3048376658 cites W2154098969 @default.
• W3048376658 cites W2157358083 @default.
• W3048376658 cites W2463798203 @default.
• W3048376658 cites W2595991414 @default.
• W3048376658 cites W2773576041 @default.
• W3048376658 cites W2793281906 @default.
• W3048376658 cites W2795441251 @default.
• W3048376658 cites W2898163060 @default.
• W3048376658 cites W2903756163 @default.
• W3048376658 cites W2910174605 @default.
• W3048376658 cites W2944894718 @default.
• W3048376658 cites W2949349304 @default.
• W3048376658 cites W2952568517 @default.
• W3048376658 cites W2955426005 @default.
• W3048376658 cites W2957390200 @default.
• W3048376658 cites W2963015093 @default.
• W3048376658 cites W2980159020 @default.
• W3048376658 cites W2981552707 @default.
• W3048376658 cites W2999417355 @default.
• W3048376658 doi "https://doi.org/10.1016/j.ygyno.2020.07.105" @default.
• W3048376658 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32800655" @default.
• W3048376658 hasPublicationYear "2020" @default.
• W3048376658 type Work @default.
• W3048376658 sameAs 3048376658 @default.
• W3048376658 citedByCount "9" @default.
• W3048376658 countsByYear W30483766582021 @default.
• W3048376658 countsByYear W30483766582022 @default.
• W3048376658 countsByYear W30483766582023 @default.
• W3048376658 crossrefType "journal-article" @default.
• W3048376658 hasAuthorship W3048376658A5003929069 @default.
• W3048376658 hasAuthorship W3048376658A5026950248 @default.
• W3048376658 hasAuthorship W3048376658A5027202188 @default.
• W3048376658 hasAuthorship W3048376658A5031453430 @default.
• W3048376658 hasAuthorship W3048376658A5034744116 @default.
• W3048376658 hasAuthorship W3048376658A5036514898 @default.
• W3048376658 hasAuthorship W3048376658A5068319278 @default.
• W3048376658 hasAuthorship W3048376658A5075065928 @default.
• W3048376658 hasAuthorship W3048376658A5078818153 @default.
• W3048376658 hasAuthorship W3048376658A5089503365 @default.
• W3048376658 hasConcept C10515644 @default.
• W3048376658 hasConcept C121608353 @default.
• W3048376658 hasConcept C126322002 @default.
• W3048376658 hasConcept C126838900 @default.
• W3048376658 hasConcept C143998085 @default.
• W3048376658 hasConcept C146357865 @default.
• W3048376658 hasConcept C150173356 @default.
• W3048376658 hasConcept C151730666 @default.
• W3048376658 hasConcept C2777088508 @default.
• W3048376658 hasConcept C2777546739 @default.
• W3048376658 hasConcept C2777863537 @default.
• W3048376658 hasConcept C2777982462 @default.
• W3048376658 hasConcept C2778938455 @default.
• W3048376658 hasConcept C57742111 @default.
• W3048376658 hasConcept C66339696 @default.
• W3048376658 hasConcept C71924100 @default.
• W3048376658 hasConcept C86803240 @default.
• W3048376658 hasConceptScore W3048376658C10515644 @default.
• W3048376658 hasConceptScore W3048376658C121608353 @default.
• W3048376658 hasConceptScore W3048376658C126322002 @default.
• W3048376658 hasConceptScore W3048376658C126838900 @default.
• W3048376658 hasConceptScore W3048376658C143998085 @default.
• W3048376658 hasConceptScore W3048376658C146357865 @default.
• W3048376658 hasConceptScore W3048376658C150173356 @default.
• W3048376658 hasConceptScore W3048376658C151730666 @default.
• W3048376658 hasConceptScore W3048376658C2777088508 @default.
• W3048376658 hasConceptScore W3048376658C2777546739 @default.
• W3048376658 hasConceptScore W3048376658C2777863537 @default.
• W3048376658 hasConceptScore W3048376658C2777982462 @default.
• W3048376658 hasConceptScore W3048376658C2778938455 @default.
• W3048376658 hasConceptScore W3048376658C57742111 @default.
• W3048376658 hasConceptScore W3048376658C66339696 @default.
• W3048376658 hasConceptScore W3048376658C71924100 @default.
• W3048376658 hasConceptScore W3048376658C86803240 @default.
• W3048376658 hasFunder F4320306095 @default.

• next